---
figid: PMC8447515__12935_2021_2202_Fig9_HTML
figtitle: 'Cancer and diabetes: the interlinking metabolic pathways and repurposing
  actions of antidiabetic drugs'
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC8447515
filename: 12935_2021_2202_Fig9_HTML.jpg
figlink: /pmc/articles/PMC8447515/figure/Fig9/
number: F9
caption: Antitumor mechanism of Thiazolidinediones (TZDs). These drugs inhibit the
  proliferation of tumor cells either through peroxisome-proliferator-activated receptor
  gamma (PPARγ)-dependent or PPARγ-independent mechanisms. In PPARγ-dependent mechanism,
  the activation of PPARγ receptor by these drugs switch on the transcription of various
  target genes which in turn help in suppressing the growth of tumor. In PPARγ- independent
  mechanisms TZDs blocks the mTOR pathway by activation of AMPK), inhibits the expression
  of prostaglandin E2 (PGE2) receptor and vascular endothelial growth factor (VEGF)
  genes as well as induction of cyclins degradation. AMP adenosine monophosphate
papertitle: 'Cancer and diabetes: the interlinking metabolic pathways and repurposing
  actions of antidiabetic drugs.'
reftext: Ahmed Olatunde, et al. Cancer Cell Int. 2021;21:499.
year: '2021'
doi: 10.1186/s12935-021-02202-5
journal_title: Cancer Cell International
journal_nlm_ta: Cancer Cell Int
publisher_name: BioMed Central
keywords: Cancer | Diabetes | Repurposing action | Anticancer drugs | Antidiabetic
  drugs
automl_pathway: 0.9439738
figid_alias: PMC8447515__F9
figtype: Figure
redirect_from: /figures/PMC8447515__F9
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8447515__12935_2021_2202_Fig9_HTML.html
  '@type': Dataset
  description: Antitumor mechanism of Thiazolidinediones (TZDs). These drugs inhibit
    the proliferation of tumor cells either through peroxisome-proliferator-activated
    receptor gamma (PPARγ)-dependent or PPARγ-independent mechanisms. In PPARγ-dependent
    mechanism, the activation of PPARγ receptor by these drugs switch on the transcription
    of various target genes which in turn help in suppressing the growth of tumor.
    In PPARγ- independent mechanisms TZDs blocks the mTOR pathway by activation of
    AMPK), inhibits the expression of prostaglandin E2 (PGE2) receptor and vascular
    endothelial growth factor (VEGF) genes as well as induction of cyclins degradation.
    AMP adenosine monophosphate
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Amph
  - SNF4Agamma
  - AMPKalpha
  - Mtor
  - Tor
  - Pvf1
  - Pvf2
  - Pvf3
  - Pvr
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - PPARA
  - PPARD
  - PPARG
  - APRT
  - MFAP1
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - MTOR
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
---
